Literature DB >> 5298335

Effect of 5-hydroxytryptophan acting from the cerebral ventricles on 5-hydroxytryptamine output and body temperature.

M B el-Hawary, W Feldberg.   

Abstract

1. In cats anaesthetized with intraperitoneal pentobarbitone sodium the third ventricle, the anterior or inferior horn of the left lateral ventricle, was perfused with 5-hydroxytryptophan (5-HTP) in different concentrations, and the effluent assayed for 5-hydroxytryptamine (5-HT) on the rat stomach strip preparation of Vane (1957).2. On perfusion of the third ventricle with 5-HTP the output of 5-HT in effluent increased, the increase depending on the 5-HTP concentration: with 1/50,000 it increased 44-69 times (mean 55), with 1/25,000, 81-83 times (mean 82) and with 1/10,000, 71-200 times (mean 128). The 5-HT output depended also on the initial output during the preceding perfusion with artificial c.s.f. The greater this initial output the greater was the maximum output reached during the 5-HTP perfusion.3. The increase in 5-HT output during perfusion of the third ventricle with 5-HTP was usually associated with shivering and a rise in rectal temperature. This association, however, was not invariably obtained, probably because of a central depressant effect of 5-HTP itself.4. On perfusion of the anterior or inferior horn of the left lateral ventricle with 5-HTP, the output of 5-HT in the effluent also increased, but to a lesser extent than in the effluent from the third ventricle. There was no association with shivering nor with a rise in rectal temperature.5. An injection of 1 or 2 mg 5-HTP into the cerebral ventricles of unanaesthetized cats produced a biphasic rise in temperature, shivering, constriction of the skin vessels followed by vasodilatation, tachypnoea, wiping and scratching movements, miaowing and long lasting sleep.6. The biphasic rise in temperature is explained as the result of two opposing effects: increased formation of 5-HT which would raise body temperature, and a central depressant effect of 5-HTP itself or of one of its metabolites which would lower body temperature.7. The initial rise in temperature and the shivering in response to an intraventricular injection of 5-HTP varied from cat to cat. In those in which these effects were strong the 5-HT output during a subsequent perfusion of the third ventricle with artificial c.s.f. was higher, and the maximum 5-HT output reached on perfusion with 5-HTP was greater than in those in which these effects had been weak.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5298335      PMCID: PMC1395845          DOI: 10.1113/jphysiol.1966.sp008042

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  13 in total

1.  EFFECTS ON TEMPERATURE OF AMINES INJECTED INTO THE CEREBRAL VENTRICLES. A NEW CONCEPT OF TEMPERATURE REGULATION.

Authors:  W FELDBERG; R D MYERS
Journal:  J Physiol       Date:  1964-09       Impact factor: 5.182

2.  A NEW CONCEPT OF TEMPERATURE REGULATION BY AMINES IN THE HYPOTHALAMUS.

Authors:  W FELDBERG; R D MYERS
Journal:  Nature       Date:  1963-12-28       Impact factor: 49.962

3.  Microanalytical procedures for fluorometric assay of brain DOPA-5HTP decarboxylase, norepinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain.

Authors:  R KUNTZMAN; P A SHORE; D BOGDANSKI; B B BRODIE
Journal:  J Neurochem       Date:  1961-02       Impact factor: 5.372

4.  The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain.

Authors:  D F BOGDANSKI; H WEISSBACH; S UDENFRIEND
Journal:  J Neurochem       Date:  1957       Impact factor: 5.372

5.  The effect of intraluminal application of 5-hydroxytryptamine and 5-hydroxytryptophan on peristalsis; the local production of 5-HT and its release in relation to intraluminal pressure and propulsive activity.

Authors:  E BULBRING; R C LIN
Journal:  J Physiol       Date:  1958-03-11       Impact factor: 5.182

6.  The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog.

Authors:  A H AMIN; T B CRAWFORD; J H GADDUM
Journal:  J Physiol       Date:  1954-12-10       Impact factor: 5.182

7.  Injections of drugs into the lateral ventricle of the cat.

Authors:  W FELDBERG; S L SHERWOOD
Journal:  J Physiol       Date:  1954-01       Impact factor: 5.182

8.  The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs.

Authors:  M VOGT
Journal:  J Physiol       Date:  1954-03-29       Impact factor: 5.182

9.  Appearance of 5-hydroxytryptamine and an unidentified pharmacologically active lipid acid in effluent from perfused cerebral ventricles.

Authors:  W Feldberg; R D Myers
Journal:  J Physiol       Date:  1966-06       Impact factor: 5.182

10.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  5 in total

1.  [New experimental results in the hypothalamus].

Authors:  W Feldberg
Journal:  Acta Neuroveg (Wien)       Date:  1967

2.  Effect on temperature of 5-hydroxytryptamine injected into the cerebral ventricles of cats.

Authors:  U Banerjee; T F Burks; W Feldberg
Journal:  J Physiol       Date:  1968-03       Impact factor: 5.182

3.  Temperature effects produced in dogs and monkeys by injections of monoamines and related substances into the third ventricle.

Authors:  W Feldberg; R F Hellon; V J Lotti
Journal:  J Physiol       Date:  1967-08       Impact factor: 5.182

4.  Monoamine oxidase inhibition: effect on 5-hydroxytryptamine output from perfused third ventricle and body temperature.

Authors:  M B el Hawary; W Feldberg; V J Lotti
Journal:  J Physiol       Date:  1967-01       Impact factor: 5.182

5.  Temperature responses and other effects of 5-hydroxytryptophan and 5-hydroxytryptamine when acting from the liquor space in unanaesthetized rabbits.

Authors:  U Banerjee; T F Burks; W Feldberg; C A Goodrich
Journal:  Br J Pharmacol       Date:  1970-04       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.